Tapan Buch

Tapan Buch practices at South Shore University Hospital in Bay Shore, New York, part of Northwell Health.

Tapan Buch's NPI, 1265970412, was assigned on February 8, 2017. Tapan Buch holds New York license 319910.

Tapan Buch's primary practice is South Shore University Hospital, at 301 East Main Street, Bay Shore, NY 11706 in Suffolk County. The practice phone is (631) 968-3000.

Tapan Buch's primary practice is South Shore University Hospital in Bay Shore, New York, part of Northwell Health. Tapan Buch is also affiliated with North Shore University Hospital. The medical group on file is Northwell Health Physician Partners Cardiology at Great Neck. Dmand AI also links Tapan Buch to 3 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Tapan Buch practices, 6 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Tapan Buch's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Tapan Buch is licensed in New York.

CMS data shows 2,755 Medicare services from Tapan Buch across 23 procedure codes in 2024, for 1,405 Medicare patients. Medicare paid $117,598 for them.

CMS counts 1,405 Medicare patients who saw Tapan Buch in 2024. The largest group is 75 to 84, with 514 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 23% are also on Medicaid. Their average risk score is 2.02, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Tapan Buch's median patient age at 69, with 50% women.

In 2024, Tapan Buch wrote 241 Medicare Part D claims for 70 patients. 87% of them were for generic drugs. CMS names the drug for 169 of them, across 10 drugs with 11 or more claims each, at $25,988 in total drug cost. In 2021, CMS named 39 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Tapan Buch for performance year 2024, reported through an alternative payment model (APM). Tapan Buch accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 3 papers to Tapan Buch, published from 2014 to 2021. Tapan Buch has published most often in Am J Cardiovasc Dis. Tapan Buch's most frequent co-authors are Karthik Gonuguntla, MD, Amreet K. Aujla, MD and Sreekant Avula, MD.

CMS Open Payments shows 36 general payments to Tapan Buch from 17 drug and device companies from 2018 to 2025. Consulting fees make up the largest share, 58% of the total. Novartis Pharmaceuticals Corporation paid the most, $1,900.